Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide
However, the most implicated factors are the inflammation and host genetic elements.
Inflammation stimulates angiogenesis, DNA damage and malignant cell growth (7) . Other risk factors to hepatocarcinogenesis include dietary aflatoxin, pesticides, chronic abuse of alcohol, metabolic and some hereditary disorders as hereditary hemochromatosis and alpha1-antitrypsin deficiency (7, 8) .
Interleukin-1beta (IL-1β), a proinflammatory cytokine that is synthesized by liver macrophages and implicated in the course of HCV (9) . High blood level of IL-1β is found in hepatitis, liver fibrosis, and liver cirrhosis and HCC patients (10).
IL1β gene is highly polymorphic and located at position 1 on the long arm of chromosome 2 (11).
One of these polymorphisms present in the promoter region at −31 positions (12) . IL-1β gene −31C/T substitution is located in the TATA box and affecting the binding of transcription initiation factors. Consequently, this affects the IL-1β transcription activity and modulates its expression (13) . Liver cirrhosis and end stage liver disease were found to be associated with gene polymorphisms of IL-1β (14) . However, the relationship between IL-1β gene polymorphisms and the occurrence of cancers has been examined and the results were controversial (15) . So the present study investigated the role of IL-1β −31 C/T polymorphism in the occurrence of HCC in
Egyptian patients with viral hepatitis (HCV, HBV) versus none-viral cause.
Subject and Methods

Study population
A 
Samples:
Whole blood sample (5 ml) was drawn from each 
Statistical Analysis
Results
Serum value of AFP
There was significant increase of AFP serum level in all HCC groups compared to control, but no significant difference was found between different HCC groups (p>0.05). Data are shown in table (1) .
Serum value of IL-1β:
There was a significant increase of IL-1β serum 
IL-1β 31 genotype and allele
There was significant increase in the frequency of TT genotype in HCC patients with HCV when compared to HCC without viral hepatitis, and control group (43.2%, 25% and 26.7%, respectively). On other hand, the CC genotype was more frequent in both control and HCC patients without viral hepatitis groups when compared to HCC with HCV or HBV (42.2%, 39.3%, 21.6%, and 20.8%, respectively). In addition, the T allele exhibited higher frequency in HCC patients with HCV or HBV than none viral HCC and the control group (60.8%, 56.2%, 42.9 and 42.2%, respectively) ( Table 2) .
Odds ratio for IL-1beta genotypes and alleles
Regarding frequency of IL-1 β alleles and genotypes and associated HCC risk; where mutant (Table 3) .
IL-1β level in different genotypes and alleles among all participants
There was highly significant increase of IL-1β level 
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